Join to view full profile
9910 Franklin Square DrSte 2110Baltimore, MD 21236
Phone+1 410-933-6423
Fax+1 321-471-1136
Dr. Seiwert is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Tanguy Seiwert is an oncologist in Baltimore, MD. He received his medical degree from Johannes Gutenberg University of Mainz Faculty of Medicine and has been in practice 18 years. He specializes in head & neck cancer and thoracic cancer.
Education & Training
Johannes Gutenberg University of Mainz Faculty of MedicineClass of 1999
Certifications & Licensure
MD State Medical License 2019 - 2026
IL State Medical License 2003 - 2020
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
- A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2012 Nov 12
- Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery Start of enrollment: 2012 Aug 20
Publications & Presentations
PubMed
- Metastatic HPV-Related Multiphenotypic Sinonasal Carcinoma: A Case Report and Review of the Literature.Rachel Stemme, Wassim Najjar, Tanguy Y Seiwert, Harry Quon, Lisa M Rooper
Journal of Neurological Surgery Reports. 2026-01-01 - 2 citationsImmune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy.Howard L Li, Soren Charmsaz, Mari Nakazawa, Stephanie L Alden, Madelena Brancati
Cancer Research Communications. 2025-10-01 - 5 citationsAnalytical and clinical performance validation of HPV-SEQ, a novel NGS-based liquid biopsy platform for detection and quantification of human papilloma virus circulati...Samaneh Eickelschulte, Anna Starus, David H Murray, Kirsten A Keyser, Oliver Schauer
Oral Oncology. 2025-08-01
Press Mentions
The Debate Surrounding Treatment De-Escalation for HPV-Positive Oropharynx CancerFebruary 26th, 2018
Reduced RT Feasible in Chemo-Sensitive HPV-Associated Head and Neck CancerFebruary 19th, 2018
Lower-Dose Radiation Therapy Effective and Safe for HPV-Related Head and Neck Cancer After Induction Chemotherapy, Trial FindsFebruary 13th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
